10Jul 2022
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy

Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy

This multicenter, prospective observational cohort study aimed to evaluate health-related quality of life (HR-QoL), psychological distress and fatigue in mCRPC patients treated with radium-223. In patients who completed therapy, stabilization of HR-QoL was perceived, and psychological pain and fatigue remained stable whereas clinically meaningful. However, statistically, significant deterioration of HR-QoL, psychological distress and fatigue over time was observed in patients who discontinued radium-223 therapy. In addition, patients who discontinued radium-223 treatment showed worse HR-QoL, psychological pain and fatigue at baseline and more frequent deterioration of HR-QoL, psychological distress and fatigue over time compared to patients who completed therapy.

  • #urology

Like

Save

Share